The DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.
X-linked adrenoleukodystrophy
Abstract
X-linked adrenoleukodystrophy (X-ALD) is caused by a defect in the gene ABCD1, which maps to Xq28 and codes for a peroxisomal membrane protein that is a member of the ATP-binding cassette transporter superfamily. X-ALD is panethnic and affects approximately 1:20,000 males. Phenotypes include the rapidly progressive childhood, adolescent, and adult cerebral forms; adrenomyeloneuropathy, which presents as slowly progressive paraparesis in adults; and Addison disease without neurologic manifestations. These phenotypes are frequently misdiagnosed, respectively, as attention-deficit hyperactivity disorder (ADHD), multiple sclerosis, or idiopathic Addison disease. Approximately 50% of female carriers develop a spastic paraparesis secondary to myelopathic changes similar to adrenomyeloneuropathy. Assays of very long chain fatty acids in plasma, cultured chorion villus cells and amniocytes, and mutation analysis permit presymptomatic and prenatal diagnosis, as well as carrier identification. The timely use of these assays is essential for genetic counseling and therapy. Early diagnosis and treatment can prevent overt Addison disease, and significantly reduce the frequency of the severe childhood cerebral phenotype. A promising new method for mass newborn screening has been developed, the implementation of which will have a profound effect on the diagnosis and therapy of X-ALD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated levels of cerotic acid (C26:0) [overall reference range 0.15–1.9 µmol/l] and the ratios C24:0/C22:0 [0.32–1.19] and C26:0/C22:0 [0.0–0.03] are used for diagnostic purposes (see cutoff level comparison in Table 1 and as previously discussed by Moser et al.9).”
From Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy (2020) · cites this paper as [9]
In the citing paper
“X-linked adrenoleukodystrophy (X-ALD) is clinically characterized by two main phenotypes: adrenomyeloneuropathy (AMN) and the cerebral demyelinating form of X-ALD (cerebral ALD) [1,2].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [2]
In the citing paper
“AMN is the most frequent phenotype of X-ALD [1,2].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [2]
Citations
Cites
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Rochester, C. L., & Kradin, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432509 · Cited by 3,875
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationAdrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases
Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475
Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain
Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440
Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3402 · Cited by 374
Self-citationAubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366
Singh, I., Moser, A. E., Goldfischer, S. L., & Moser, H. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.4203 · Cited by 348
Self-citation
Research works printed but not linked: 2
- Koehler W and Sokolowski P (2005) Clinical phenotypes, diagnosis and treatment of adulthood X-linked adrenoleukodystrophy. In Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives, 28–60 (Eds Berger J et al.) SPS Verlagsgessellschaft: Heilbronn
- Mahmood A et al. (2005) Evaluating survival in nontransplanted boys with the cerebral phenotype of X-linked adrenoleukodystrophy [abstract]. Ann Neurol 58 (Suppl 9): 52a
Cited by
Sorted by citations
Items 301–400 of 664
Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia
Chen, Y., Lee, Y., Tsai, Y., Guo, Y., Hsiao, C.-T., Tsai, P., Huang, J., Liao, Y., & Soong, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177296 · Cited by 18
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
Volmrich, A. M., Cuénant, L. M., Forghani, I., Hsieh, S. L., & Shapiro, L. T. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s359479 · Cited by 19
Monternier, P., Singh, J., Parasar, P., Theurey, P., DeWitt, S. H., Jacques, V., Klett, E. L., Kaur, N., Nagaraja, T. N., Moller, D. E., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12510 · Cited by 17
Jiang, M., Cai, Y.-N., Liang, C., Peng, M.-Z., Sheng, H., Fan, L.-P., Lin, R., Jiang, H., Huang, Y., & Liu, L. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9717-6 · Cited by 18
Marchetti, D. P., Reinhardt, L. S., Jacques, C. E. D., Guerreiro, G., Mescka, C. P., Deon, M., Coelho, D. D. M., Moura, D. J., Viario, A. G., Poletto, F. S., et al. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0626-1 · Cited by 17
Sener, R. N. (2002) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(02)00489-7 · Cited by 17
Hama, K., Fujiwara, Y., Takashima, S., Hayashi, Y., Yamashita, A., Shimozawa, N., & Yokoyama, K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.p119000325 · Cited by 16
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.
Metovic, J., Li, Y., Gong, Y., & Eichler, F. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00443 · Cited by 16
Addisonian crisis in a young man with atypical anorexia nervosa
Allolio, B., Lang, K., & Hahner, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.211 · Cited by 16
Post‐transplant adaptive function in childhood cerebral adrenoleukodystrophy
Pierpont, E. I., McCoy, E., King, K. E., Ziegler, R. S., Shanley, R., Nascene, D. R., Raymond, G. V., Phelan, R., Lund, T. C., Orchard, P. J., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.526 · Cited by 16
Self-citationCurrent Therapeutic Approaches in Leukodystrophies: A Review
Gordon‐Lipkin, E. M., & Fatemi, A. S. (2018) · Journal of Child Neurology · doi:10.1177/0883073818792313 · Cited by 18
Clinical and Neuroimaging Spectrum of Peroxisomal Disorders
Tan, A. P., Gonçalves, F. G., Almehdar, A., & Soares, B. P. (2018) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000172 · Cited by 16
Wang, L., Liu, Y., Meng, L. M., Li, C. G., & Zhou, S. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00627.x · Cited by 16
Filippo, M. D., Luchetti, E., Prontera, P., Donti, E., Floridi, P., Gregorio, M. D., Tambasco, N., Sarchielli, P., & Calabresi, P. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5726-x · Cited by 16
Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP
Guimarães, C. P., Lemos, M., Menezes, I., Coelho, T., Sá-Miranda, C., & Azevedo, J. E. (2001) · Human Genetics · doi:10.1007/s00439-001-0632-z · Cited by 16
X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers
Lourenço, C. M., Simão, G. N., dos Santos, A. C., & Marques, W. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000700003 · Cited by 16
Wu, C., Iwamoto, T., Igarashi, J., Miyajima, T., Hossain, M. A., Yanagisawa, H., Akiyama, K., Shintaku, H., & Eto, Y. (2017) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2017.06.004 · Cited by 16
Treating inflammation in childhood neurodegenerative disorders
Lim, M. J. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03902.x · Cited by 16
Mass spectrometric studies on brain metabolism, using stable isotopes
Ando, S., & Tanaka, Y. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20045 · Cited by 16
Clinical magnetic resonance spectroscopy of the central nervous system
Ratai, E., & González, R. G. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00005-2 · Cited by 16
X-linked adrenoleukodystrophy presenting as autosomal dominant pure hereditary spastic paraparesis
Shaw-Smith, C. J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.022970 · Cited by 16
The value of new MRI techniques in adrenoleukodystrophy
Engelbrecht, V., Rassek, M., Gärtner, J., M�dder, U., & Kahn, T. (1997) · Pediatric Radiology · doi:10.1007/s002470050103 · Cited by 16
Functional characterization of the adrenoleukodystrophy protein (ALDP) and disease pathogenesis
Gärtner, J., Dehmel, T., Klusmann, A., & Roerig, P. (2002) · Endocrine Research · doi:10.1081/erc-120016999 · Cited by 15
Implication of Oxysterols and Phytosterols in Aging and Human Diseases
Vigne, S., & Pot, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_12 · Cited by 16
Park, C., Kim, H.-S., Jang, J., Lee, H., Lee, J. S., Yoo, J., Lee, D. R., & Kim, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056242 · Cited by 14
Boychuk, N., Mulrooney, N., Kelly, N. R., Goldenberg, A. J., Silver, E. J., & Wasserstein, M. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8040059 · Cited by 16
Morita, M., Kobayashi, J., Yamazaki, K., Kawaguchi, K., Honda, A., Sugai, K., Shimozawa, N., Koide, R., & Imanaka, T. (2012) · JIMD Reports · doi:10.1007/8904_2012_209 · Cited by 15
Metabolic disorders causing childhood ataxia
Parker, C. C., & Evans, O. B. (2003) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(03)00028-7 · Cited by 15
Amorosi, C. A., Myšková, H., Monti, M. R., Argaraña, C. E., Morita, M., Kemp, S., de Kremer, R. D., Dvořáková, L., & Ramírez, A. M. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052635 · Cited by 15
Adrenoleukodystrophy in the era of newborn screening
Eng, L., & Regelmann, M. O. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000515 · Cited by 15
Adreno-leukodystrophy: A personal historical note
Powers, J. M. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0961-9 · Cited by 15
The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
Berdowski, W. M., Sanderson, L. E., & van Ham, T. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048925 · Cited by 15
Genetic testing for paediatric neurological disorders
Valente, E. M., Ferraris, A., & Dallapiccola, B. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70257-6 · Cited by 14
Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible
Cappa (2011) · PubMed · doi:10.3275/7570 · Cited by 14
Giant platelets in erucic acid therapy for adrenoleukodystrophy
Stöckler, S., Molzer, B., Plecko, B., Zenz, W., Muntean, W. E., Söling, U., HUNNEMAN, D. H., Korenke, G. C., & Hanefeld, F. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90984-o · Cited by 14
ABCD1 mutations and phenotype distribution in Chinese patients with X-linked adrenoleukodystrophy
Niu, Y., Wang, N., & Wu, Z. (2013) · Gene · doi:10.1016/j.gene.2013.03.067 · Cited by 13
Benedetto, R. D., Denti, M. A., Salvati, S., Sanchez, M., Attorri, L., David, G., & Biase, A. D. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.11.007 · Cited by 14
Myelin and disorders that affect the formation and maintenance of this sheath
Porter, B. E., & Tennekoon, G. I. (2000) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/(sici)1098-2779(2000)6:1 · Cited by 14
Inoue, K., Suzuki, Y., Yajima, S., Shimozawa, N., Orii, T., & Kondo, N. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2197 · Cited by 14
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis
Stys, P. K., Tsutsui, S., Gafson, A., Hart, B. A. ‘., Belachew, S. M., & Geurts, J. J. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1426231 · Cited by 14
X-linked adrenoleukodystrophy: are signs of hypogonadism always due to testicular failure?
Karapanou, O., Vlassopoulou, B., Tzanela, M., Papadopoulos, D., Angelidakis, P., Michelakakis, H., Ioannidis, G., Mihalatos, M., Kamakari, S., & Tsagarakis, S. (2014) · HORMONES · doi:10.1007/bf03401330 · Cited by 13
Induced pluripotent stem cells for modeling of pediatric neurological disorders
Jang, J., Quan, Z., Yum, Y. J., Song, H. S., Paek, S., & Kang, H. (2014) · Biotechnology Journal · doi:10.1002/biot.201400010 · Cited by 14
Parents of childhood X-linked adrenoleukodystrophy: High risk for depression and neurosis
Kuratsubo, I., Suzuki, Y., Shimozawa, N., & Kondo, N. (2008) · Brain and Development · doi:10.1016/j.braindev.2007.12.012 · Cited by 13
Adrenomyeloneuropathy in Patients with ‘Addison's Disease’: Genetic Case Analysis
Mukherjee, S., Newby, E., & Harvey, J. N. (2006) · Journal of the Royal Society of Medicine · doi:10.1177/014107680609900516 · Cited by 13
Chu, S., Ye, J., Zhang, H., Han, L.-S., Qiu, W., Gao, X., & Gu, X. (2015) · World Journal of Pediatrics · doi:10.1007/s12519-015-0044-0 · Cited by 12
Circadian rhythm abnormalities in adrenoleukodystrophy and methyl B12 treatment
Tomoda, A., Miike, T., & Matsukura, M. (1995) · Brain and Development · doi:10.1016/0387-7604(95)00083-6 · Cited by 13
Bamiou, D., Davies, R. A., Jones, S., Musiek, F. E., Rudge, P., Stevens, J., & LUXON, L. M. (2004) · Journal of the American Academy of Audiology · doi:10.3766/jaaa.15.2.5 · Cited by 13
Gene and Cellular Therapies for Leukodystrophies
Aerts‐Kaya, F., & van Til, N. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112522 · Cited by 14
Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms
Parasar, P., Kaur, N., & Singh, J. (2024) · Journal of Biotechnology and Biomedicine · doi:10.26502/jbb.2642-91280151 · Cited by 12
Biomarkers predictive of long-term fertility found in vaginal lipidome of gilts at weaning
Mills, K. M., Ferreira, C. R., Stevens, J. G., Stewart, K. R., & Casey, T. (2021) · Journal of Animal Science · doi:10.1093/jas/skab189 · Cited by 12
Progression rate of myelopathy in X-linked adrenoleukodystrophy heterozygotes
Habekost, C. T., Pereira, F. D. S., Vargas, C. R., Coelho, D. D. M., Torrez, V. R., Oses, J. P., Portela, L. V., Schestatsky, P., Torres, V. F., Matte, Ú. D. S., et al. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9672-2 · Cited by 12
Gueugnon, F., Gondcaille, C., Leclercq, S., Bellenger, J., Bellenger, S., Narce, M., Pineau, T., Bonnetain, F., & Savary, S. (2007) · Biochimie · doi:10.1016/j.biochi.2007.06.013 · Cited by 12
Kallabi, F., Salem, I. H., Chehida, A. B., Salah, G. B., Turkia, H. B., Tebib, N., Keskes, L., & Kamoun, H. (2015) · Neuroscience Research · doi:10.1016/j.neures.2015.03.005 · Cited by 12
Zarrouk, A., Hammami, M., Moreau, T., & Lizard, G. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2014.10.016 · Cited by 12
Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease: Figure 1
Nascimento, M., Rodrigues, N., Espada, F., & Fonseca, M. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-006308 · Cited by 12
Adult-Onset Leukoencephalopathies
Renaud, D. L. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000303 · Cited by 13
Basu, C., AHMED, M. A., Kartha, R. V., Brundage, R. C., Raymond, G. V., Cloyd, J. C., & Carlin, B. P. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2016.1226326 · Cited by 11
Self-citationPlastic structures for diverse substrates: A revisit of human ABC transporters
Hou, W., Xu, D., Wang, L., Chen, Y., Chen, Z., Zhou, C., & Chen, Y. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26406 · Cited by 12
Evaluation of Neuroinflammation in X-Linked Adrenoleukodystrophy
Kumar, A., Chugani, H. T., Chakraborty, P. K., & Huq, A. H. M. M. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2010.10.006 · Cited by 12
Very long chain fatty acid levels in patients diagnosed with multiple sclerosis
Wilkins, A., Ingram, G., Brown, A., Jardine, P. E., Steward, C. G., Robertson, N. P., & Scolding, N. J. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509351731 · Cited by 12
Hematopoietic stem cell transplantation in leukodystrophies
Sevin, C., & Mochel, F. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00017-x · Cited by 12
Puig-Serra, P., Hinckley-Boned, A., Tristán‐Manzano, M., Rı́o, P., Torres-Ruiz, R., Rodríguez, S., & Martı́n, F. (2025) · Human Gene Therapy · doi:10.1177/10430342251372474 · Cited by 11
Walkley, S. U., Abbeduto, L., Batshaw, M. L., Bhattacharyya, A., Bookheimer, S. Y., Christian, B. T., Constantino, J. N., de Vellis, J., Doherty, D., Nelson, D. L., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25531 · Cited by 11
Pierpont, E. I., Isaia, A., McCoy, E., Brown, S. J., Gupta, A. O., & Eisengart, J. B. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12581 · Cited by 12
Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans
Gong, Y., Laheji, F., Berenson, A., Li, Y., Moser, A., Qian, A., Frosch, M., Sadjadi, R., Hahn, R., Maguire, C. A., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26849 · Cited by 11
Keller, J. L., Wang, J. I., Kang, J. Y., Hanson, J. A., Kamath, P., Swain, J. O., Raymond, G. V., & Zackowski, K. M. (2012) · Neurorehabilitation and neural repair · doi:10.1177/1545968312441682 · Cited by 11
Self-citationTang, H. T., Matteson, J., Rinaldo, P., Tortorelli, S., Currier, R. J., & Sciortino, S. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030062 · Cited by 12
Stradomska, T. J., & Tylki‐Szymańska, A. (2009) · PubMed · Cited by 11
Oka, A., Saito, M., Kubota, M., Sakakihara, Y., & Yanagisawa, M. (1996) · Brain and Development · doi:10.1016/0387-7604(95)00106-9 · Cited by 11
Principes et contraintes des régimes au cours des maladies neurométaboliques chez l’adulte
Crenn, P. P., & Maillot, F. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)92637-5 · Cited by 11
Clinical and biochemical characteristics of peroxisomal disorders: an update
Wanders, R. J. A., Barth, P. G., Schutgens, R. B. H., & Tager, J. M. (1994) · European Journal of Pediatrics · doi:10.1007/bf02138777 · Cited by 11
Diagnosis of X-linked adrenoleukodystrophy in blood leukocytes
Unterberger, U., Regelsberger, G., Sundt, R., Bernheimer, H., & Voigtländer, T. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.04.015 · Cited by 10
Soardi, F. C., Esquiaveto‐Aun, A. M., Guerra‐Júnior, G., de Lemos‐Marini, S. H. V., & de Mello, M. P. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000800013 · Cited by 10
Sakurai, K., Ohashi, T., Shimozawa, N., Seo, J.-H., Okuyama, T., & Ida, H. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.07.007 · Cited by 10
Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy
Lin, J. E., Armour, E. A., Heshmati, A., Umandap, C. H., Couto, J. J., Iglesias, A. D., Mallack, E. J., & Bain, J. (2019) · Neurology · doi:10.1212/wnl.0000000000007755 · Cited by 10
Morita, M., Toida, A., Horiuchi, Y., Watanabe, S., Sasahara, M., Kawaguchi, K., So, T., & Imanaka, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06228 · Cited by 11
Dong, L.-W., Xiao, J., Liu, S., Deng, G., Liao, Y.-C., Chu, B., Zhao, X., Song, B., & Luo, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2260-4 · Cited by 10
Decreasing serum VLCFA levels in ageing X‐ALD female carriers
Stradomska, T. J., & Tylki‐Szymańska, A. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1013992224811 · Cited by 10
Biochemical effect of intravenous arginine butyrate in x-linked adrenoleukodystrophy
McGovern, M. M., Wasserstein, M., Aron, A. M., & Perrine, S. P. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.201 · Cited by 10
Simon, D. K., Rodríguez, M., Frosch, M. P., Quackenbush, E. J., Feske, S. K., & Natowicz, M. R. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.251 · Cited by 10
Lorenzo’s Oil: Advances in the Treatment of Neurometabolic Disorders
Ferri, R. T., & Chance, P. F. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1045 · Cited by 10
Adult cerebral adrenoleukodystrophy and Addison's disease in a female carrier
Chen, X., Chen, Z., Huang, D., Liu, X., Gui, Q., & Yu, S. (2014) · Gene · doi:10.1016/j.gene.2014.04.056 · Cited by 11
X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES
Furlan, F. L. S., Lemes, M. A., Suguimatsu, L. C. F., Pires, C. T. F., & Santos, M. L. S. F. (2019) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/;2019;37;4;00015 · Cited by 10
Triantafyllou, P., Economou, M. P., Vlachaki, E., Aggelaki, M., Athanassiou‐Metaxa, M., Michelakaki, E., & Zafeiriou, D. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.01.027 · Cited by 9
Advances In the Diagnosis of Leukodystrophies
Osterman, B., Piana, R. L., & Bernard, G. (2012) · Future Neurology · doi:10.2217/fnl.12.52 · Cited by 9
Dementia from the ABCD1 mutation c.1415-1416delAG in a female carrier
Finsterer, J., Lässer, S., & Stöphasius, E. (2013) · Gene · doi:10.1016/j.gene.2013.07.073 · Cited by 9
Three Novel Variants in X-linked Adrenoleukodystrophy
Shukla, P., Gupta, N., Kabra, M., Ghosh, M., Sharma, R., Gupta, A. K., Gulati, S., & Kalra, V. (2009) · Journal of Child Neurology · doi:10.1177/0883073808330764 · Cited by 9
Multi-Institutional Assessments of Transplantation for Metabolic Disorders
Orchard, P. J., Boelens, J. J., & Raymond, G. V. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.10.026 · Cited by 9
Self-citationRetinal Ganglion Cell Loss in X-linked Adrenoleukodystrophy with anABCD1Mutation (Gly266Arg)
Ohkuma, Y., Hayashi, T., Yoshimine, S., Tsuneoka, H., Mikami-Terao, Y., Akiyama, M., Ida, H., Ohashi, T., Okumura, A., Ebihara, N., et al. (2014) · Neuro-Ophthalmology · doi:10.3109/01658107.2014.950430 · Cited by 9
Case 1-2009: A 57-Year-Old Man with Progressive Cognitive Decline
Costello, D. J., Eichler, F. S., Grant, P. E., & Auluck, P. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmcpc0807820 · Cited by 9
Late onset adrenoleukodystrophy: A review related clinical case report
Paláu-Hernández, S., Rodríguez‐Leyva, I., & Shiguetomi-Medina, J. M. (2019) · eNeurologicalSci · doi:10.1016/j.ensci.2019.01.007 · Cited by 8
Zhang, T., Yan, C., Liu, Y., Cao, L., Ji, K., Li, D., Chi, L., & Zhao, Y. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s296424 · Cited by 9
Weber, T., & Köhler, W. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-2948-1 · Cited by 9
Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment
Zhang, L. X. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.822 · Cited by 9
A novel cell model to study the function of the adrenoleukodystrophy-related protein
Gueugnon, F., Volodina, N., Taouil, J. E., Lopez, T. E., Gondcaille, C., Grand, A. S.-L., Mooijer, P. A. W., Kemp, S., Wanders, R. J. A., & Savary, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.152 · Cited by 9
Weber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103742 · Cited by 8
Sevin, C., Hatteb, S. A., Clément, A., Bignami, F., Chillotti, L., Bugnard, F., Bénard, S., & Boespflug‐Tanguy, O. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02843-x · Cited by 8
Inoue, S., Terada, S., Matsumoto, T., Ujike, H., & Uchitomi, Y. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6899 · Cited by 8
Exome sequencing identifies mutations in ABCD1 and DACH2 in two brothers with a distinct phenotype
Zhang, Y., Liu, Y., Li, Y., Duan, Y., Zhang, K., Wang, J., & Dai, Y. (2014) · BMC Medical Genetics · doi:10.1186/preaccept-6007503310713758 · Cited by 8
Brownstone, E., Voigtländer, T., Baumhackl, U., & Finsterer, J. (2012) · Gene · doi:10.1016/j.gene.2012.10.076 · Cited by 8
Metadata
- Authors
- Moser, H. W., Mahmood, A., & Raymond, G. V.
- Affiliations
- Kennedy Krieger Institute (US)
- Corresponding author
- Raymond, Gerald V
- ORCID
- Raymond, Gerald V
- Venue
- Nature Clinical Practice Neurology
- Published
- 2007-03
- Volume
- 3
- Issue
- 3
- Pages
- 140-151
- ISSN
- 1745-834X (ISSN-L)
- 1745-8358
- OpenAlex
- W2222090074
- Cited by
- 663
- References
- 99
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 26 · 2023: 22 · 2022: 20 · 2021: 21 · 2020: 28 · 2019: 17 · 2018: 23 · 2017: 24 · 2016: 27 · 2015: 21 · 2014: 39 · 2013: 28 · 2012: 39
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Clinical Practice Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (M0-1-R00052)
- National Center for Research Resources
- NIH Clinical Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039276, HD-10981, HD39276, P01HD010981)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- X-linked adrenoleukodystrophy, ABCD1 gene, very long chain fatty acids, peroxisomal membrane proteins, ABC transporters, adrenomyeloneuropathy, Addison's disease, newborn screening, prenatal diagnosis, carrier identification, Lorenzo's oil, genetic counseling, misdiagnosis
- MeSH terms
- Adrenoleukodystrophy, Drug Combinations, Erucic Acids, Humans, Magnetic Resonance Imaging, Phenotype, Triolein, Hematopoietic Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review